Judy Zander
美国食品药品管理局(FDA) 药物警戒与流行病学部主任

  朱迪 · 赞德博士现任美国食品药品管理局(FDA)药品评价与研究中心(CDER)监测与流行病办公室(OSE)的药物警戒与流行病学部(OPE)主任。她负责药物警戒一处和二处。这两个处室负责开展药品安全流行病工作和药物警戒项目。

  赞德博士2017年1月加入FDA。她在药品行业工作20多年,有丰富的药品安全和风险管理方面的经验。在参比制剂和仿制药产品方面,她在临床研发、上市后使用以及所有治疗方面都经验丰富。

  在加入FDA之前,赞德博士在全球药物警戒任负责制药科学战略的副总裁。

  赞德博士曾先后任职于阿斯利康、诺华和强生公司。主要负责领导和支持公司内部、外部药物警戒工作,包括成为国际医学组织理事会(CIOMS)第九专家工作组成员,负责风险管理工具的应用工作。

  赞德博士是执业和董事认证的内科医生。她在布鲁克林大学获得化学学士学位,在纽约医学院获得医学学位。

  赞德博士业余还好是骑自行车,她也非常喜欢与家人共度时光。

  Judy Zander is the Director of the Office of Pharmacovigilance and Epidemiology (OPE), in the Office of Surveillance and Epidemiology (OSE), in the Center for Drug Evaluation (CDER) at the U.S. Food and Drug Administration (FDA). In this capacity, she oversees the Divisions of Pharmacovigilance 1 and 2, the Divisions of Epidemiology 1 and 2, including drug safety epidemiology activities and pharmacovigilance programs.

  Judy joined FDA in January 2017. She has more than 20 years of pharmaceutical industry experience in drug safety, and risk management. She has experience with branded and generic products, from clinical development through post market use, in all therapeutic areas.

  Prior to joining FDA, Judy was the Vice President of medical scientific strategy in Global Pharmacovigilance.

  Judy held prior positions with increasing responsibility at AstraZeneca, Novartis, and Johnson and Johnson. She has supported and lead internal and external pharmacovigilance activities, including being a member of the CIOMS IX Expert working group regarding the application of Risk Management Tools.

  Judy is a licensed and board certified internist. She earned her medical degree from New York Medical College and a bachelor’s degree in chemistry from Brooklyn College.

  In her free time, Judy enjoys biking and spending time with her family.